Exchange: NASDAQ·Updated 06:30 PM EDT
QTRX logo

QTRXQuanterix Corp

$3.85
$0.095
(2.40%)
Today
Closed $3.87
$0.0113
(0.29%)
After Hours
EarningsAug 6
Mkt Cap$182.06M
Vol529,119.00
News
all
press releases
Quanterix Corporation Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
Quanterix Corporation (Quanterix or the Company) (NASDAQ: QTRX), a global leader in precision biomarker science, today announced that on July 15, 2026, an inducement grant (the Inducement Grant) was made to Jason Faessler in connection with the commencement of his employment as the Chief Financial...
Business Wire
News Placeholder
More News
News Placeholder
Anthem Blue Cross and Blue Shield Establishes Commercial Coverage for LucentAD Complete; Quanterix to Present New Data Highlighting Multi-Analyte Advantages
Quanterix Corporation (NASDAQ: QTRX), a global leader in precision biomarker science, today announced a series of milestones that significantly advance the clinical adoption of blood-based Alzheimers testing. Together, these milestones reinforce the growing role of LucentAD Complete, Quanterixs...
Business Wire
News Placeholder
Tuesday Sector Laggards: Medical Instruments & Supplies, Cigarettes & Tobacco Stocks
In trading on Tuesday, medical instruments & supplies shares were relative laggards, down on the day by about 2.5%. Helping drag down the group were shares of Enovis, off about 11.2% and shares of Quanterix off about 9% on the day. Also lagging the market Tuesday are cigar...
Nasdaq News: Markets
News Placeholder
Quanterix Stock Is Popping In Pre-Market: Here's Why
Quanterix shares surged 5.28% in pre-market trading on Wednesday to $3.39, reversing the prior day's losses.read more...
Benzinga
News Placeholder
TRIB, QTRX, RCON: Why These Stocks Are Surging After-Hours Today
The small-cap stocks surged between 6% and 27% after hours on Tuesday.
Stocktwits
News Placeholder
Quanterix Corporation Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Quanterix Corporation (Quanterix or the Company) (NASDAQ: QTRX), a company transforming healthcare by accelerating biomarker breakthroughs from discovery to diagnostics, today announced that on June 15, 2026, inducement grants (the Inducement Grants) were made to three employees in connection with...
Business Wire
News Placeholder
Quanterix Announces Appointment of Jason Faessler as Chief Financial Officer
Quanterix Corporation (Nasdaq: QTRX), a company transforming healthcare by accelerating biomarker breakthroughs from discovery to diagnostics, today announced the appointment of Jason Faessler as the Companys new Chief Financial Officer, effective June 22. Faessler brings extensive finance...
Business Wire
News Placeholder
Quanterix Appoints Industry Veteran Geoff Albrecht as Senior Vice President and General Manager of Diagnostics
Quanterix Corporation (Nasdaq: QTRX), a company transforming healthcare by accelerating biomarker breakthroughs from discovery to diagnostics, today announced the appointment of Geoff Albrecht as Senior Vice President and General Manager of Diagnostics. This strategic hire underscores Quanterixs...
Business Wire
News Placeholder
Quanterix To Participate in the Goldman Sachs 47th Annual Global Healthcare Conference
Quanterix Corporation (Nasdaq: QTRX), a company transforming healthcare by accelerating biomarker breakthroughs from discovery to diagnostics, today announced that senior management will participate in the Goldman Sachs 47th Annual Global Healthcare Conference being held in Miami, FL from June...
Business Wire
News Placeholder
Quanterix Corporation Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Quanterix Corporation (Quanterix or the Company) (NASDAQ: QTRX), a company transforming healthcare by accelerating biomarker breakthroughs from discovery to diagnostics, today announced that on May 15, 2026, an inducement grant (the Inducement Grant) was made to Anthony Catalano in connection with...
Business Wire
<
1
2
...
>

Advertisement|Remove ads.